Comparison Overview
AUROBINDO PHARMA LTD
AUROBINDO PHARMA LTD
Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District,, Hyderabad, 500032, IN
Last Update: 03/04/2026
Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, brand...
Novartis
Novartis Campus, Basel, 4002, CH
Last Update: 20/05/2026
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million pe...
Compliance Ranges Comparison
AUROBINDO PHARMA LTD
Novartis
Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for AUROBINDO PHARMA LTD in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
Novartis has 3.85% fewer incidents than the average of all companies with at least one recorded incident.
Incident History - AUROBINDO PHARMA LTD (X = Date, Y = Severity)
AUROBINDO PHARMA LTD cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Novartis (X = Date, Y = Severity)
Novartis cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
AUROBINDO PHARMA LTD
Novartis
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.